title: Hypertensive Emergencies in Pregnancy.
abstract: The prevalence of hypertensive disorders in pregnancy is increasing. The etiology and pathophysiology of hypertensive disorders in pregnancy remain poorly understood. Hypertensive disorders are a major cause of maternal and perinatal morbidity and mortality. Treatment of hypertension decreases the incidence of severe hypertension, but it does not impact rates of preeclampsia or other pregnancy complications. Several antihypertensive medications are commonly used in pregnancy, although there is a lack of randomized controlled trials. Severe hypertension should be treated immediately to prevent maternal end-organ damage. Appropriate antepartum, intrapartum, and postpartum management is important in caring for patients with hypertensive disorders.
authors.affiliation: Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 668, Rochester, NY 14642, USA.
authors.forename: Courtney
authors.initials: C
authors.lastname: Olson-Chen
authors.affiliation: Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 668, Rochester, NY 14642, USA. Electronic address: Neil_Seligman@urmc.rochester.edu.
authors.forename: Neil S
authors.initials: NS
authors.lastname: Seligman
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002585:Cesarean Section / Q000592:standards; D002908:Chronic Disease; D000013:Congenital Abnormalities / Q000453:epidemiology* / Q000209:etiology; D004630:Emergencies; D004933:Esophageal Atresia / Q000453:epidemiology / Q000209:etiology; D005260:Female; D006330:Heart Defects, Congenital / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D046110:Hypertension, Pregnancy-Induced / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*; D007021:Hypospadias / Q000453:epidemiology / Q000209:etiology; D007741:Labetalol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007751:Labor, Induced / Q000592:standards; D008297:Male; D009543:Nifedipine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011181:Postnatal Care; D011225:Pre-Eclampsia / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000453:epidemiology*; D015995:Prevalence; D014481:United States / Q000453:epidemiology
chemical_list: D000959:Antihypertensive Agents; D006830:Hydralazine; D009543:Nifedipine; D007741:Labetalol
keywords: Antihypertensive medications; Gestational hypertension; Hypertensive disorders; Preeclampsia; Pregnancy